Respiratory Devices Accessories Market Analysis Report 2023: Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Respiratory Device Accessories Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Respiratory Devices Accessories market for the year 2020 and beyond. Respiratory Device Accessories are commonly used in hospitals, home settings, and long-term care facilities. The devices are available from device manufacturers and third party suppliers. In addition to epidemiological considerations, technological advancement in these accessories drives the growth of the market. The lack of awareness of respiratory conditions leading to a large undiagnosed and untreated population is the major challenge in this market.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Respiratory Device Accessories and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Respiratory Device Accessories market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

.Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, The analyst analysts provide unique country specific insights on the market.
  • SWOT analysis for Respiratory Device Accessories market.
  • Competitive dynamics insights and trends provided for Respiratory Device Accessories market.

Scope

  • CMO executives who must have deep understanding of the Respiratory Device Accessories marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

A selection of companies mentioned in this report includes, but is not limited to:

  • Fisher & Paykel Healthcare Corporation Ltd
  • Philips Respironics Inc
  • Medtronic Plc
  • Vyaire Medical Inc
  • Dragerwerk AG & Co KGaA
  • Becton Dickinson and Co
  • Ambu A/S
  • Teleflex Inc
  • Medline Industries LP
  • ResMed Inc
  • Cardinal Health Inc
  • Armstrong Medical Ltd
  • ICU Medical Inc
  • Intersurgical Ltd.
  • Laerdal Medical AS
  • PARI Medical Holding GmbH

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version